MARYA BOLYANATZ: Open Payments
NPI 1164415501 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,043 in 39 payments from 5 companies in 2025. Trend: 2023 $1,627 · 2024 $3,424 · 2025 $17,043
Speaker / faculty: $16,322Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 27 | $16,322 |
| Ascensia Diabetes Care Us Inc. | 7 | $306 |
| Novo Nordisk Inc | 3 | $225 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Sequel Med Tech, LLC | 1 | $65 |
Products named: OMNIPOD, DUPIXENT, Ozempic, TWIIST, Rybelsus.
Industry payments across CA — which companies pay providers there.
